ASH Impact Series: Jennifer Brown, MD, PhD - Treating High-Risk CLL

Jennifer Brown, MD, PhD, discusses combination strategies for high-risk CLL, compelling treatment approaches for achieving and maintaining negative minimal residual disease for patients with high-risk CLL, and more. Dr. Brown presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat CLL: High-Risk Genetics." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.